These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 34413671)

  • 1. IRF7 as an Immune-Related Prognostic Biomarker and Associated with Tumor Microenvironment in Low-Grade Glioma.
    Peng S; Wang G; Cheng Z; Guo Z
    Int J Gen Med; 2021; 14():4381-4393. PubMed ID: 34413671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening TCGA database for prognostic genes in lower grade glioma microenvironment.
    Ni J; Liu S; Qi F; Li X; Yu S; Feng J; Zheng Y
    Ann Transl Med; 2020 Mar; 8(5):209. PubMed ID: 32309356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment.
    Wang F; Tao Z; Tian Z; Jin J; Dong J; Dai Y; Yu W; Tang B; Hu S
    Front Genet; 2022; 13():874896. PubMed ID: 35865011
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune-Related Gene SERPINE1 Is a Novel Biomarker for Diffuse Lower-Grade Gliomas
    Huang X; Zhang F; He D; Ji X; Gao J; Liu W; Wang Y; Liu Q; Xin T
    Front Oncol; 2021; 11():646060. PubMed ID: 34094933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Zhang Q; Hong J
    Front Genet; 2020; 11():363. PubMed ID: 32351547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
    Hao YP; Wang WY; Qiao Q; Li G
    Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New biomarker: the gene HLA-DRA associated with low-grade glioma prognosis.
    Chen D; Yao J; Hu B; Kuang L; Xu B; Liu H; Dou C; Wang G; Guo M
    Chin Neurosurg J; 2022 May; 8(1):12. PubMed ID: 35585639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of tumor microenvironment-related genes in lower-grade gliomas by mining TCGA database.
    Liang H; Huang C
    Transl Cancer Res; 2020 Aug; 9(8):4583-4595. PubMed ID: 35117823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker GPSM3 in Low-Grade Gliomas.
    Wang M; Jia J; Cui Y; Peng Y; Jiang Y
    Brain Sci; 2021 Nov; 11(11):. PubMed ID: 34827528
    [No Abstract]   [Full Text] [Related]  

  • 14. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
    Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
    Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma.
    Zhu J; Lin Q; Zheng H; Rao Y; Ji T
    Front Oncol; 2022; 12():897042. PubMed ID: 36505882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
    Shi T; Gao G
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
    Zhong J; Xiang D; Ma X
    Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
    Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
    Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFβ1: An Indicator for Tumor Immune Microenvironment of Colon Cancer From a Comprehensive Analysis of TCGA.
    Wang J; Wang J; Gu Q; Yang Y; Ma Y; Zhang Q
    Front Genet; 2021; 12():612011. PubMed ID: 33995472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma.
    Qiu H; Tian W; He Y; Li J; He C; Li Y; Liu N; Li J
    Front Oncol; 2021; 11():654350. PubMed ID: 33954112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.